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COPDAirway epithelium alterations, including squamous cell metaplasia, characterize smokers with and without
chronic obstructive pulmonary disease (COPD). The p21 regulates cell apoptosis and differentiation and its
role in COPD is largely unknown. Molecules regulating apoptosis (cytoplasmic p21, caspase-3), cell cycle
(nuclear p21), proliferation (Ki67/PCNA), and metaplasia (survivin) in central airways from smokers (S),
smokers-COPD (s-COPD) and non-smokers (Controls) were studied. The role of cigarette smoke extracts
(CSE) in p21, survivin, apoptosis (caspase-3 and annexin-V binding) and proliferationwas assessed in a bronchi-
al epithelial cell line (16HBE). Immunohistochemistry, image analysis in surgical samples and ﬂow-cytometry
and carboxyﬂuorescein succinimidyl ester proliferative assay in 16HBE with/without CSE were applied. Cyto-
plasmic and nuclear p21, survivin, and Ki67 expression signiﬁcantly increased in large airway epithelium in S
and in s-COPD in comparison to Controls. Caspase-3 was similar in all the studied groups. p21 correlated with
epithelial metaplasia, PCNA, and Ki67 expression. CSE increased cytoplasmic p21 and survivin expression but
not apoptosis and inhibited the cell proliferation in 16HBE. In large airway epithelium of smokers with andwith-
out COPD, the cytoplasmic p21 inhibits cell apoptosis, promotes cell proliferation and correlates with squamous
cell metaplasia thus representing a potential pre-oncogenic hallmark.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The bronchial epithelium has a central role in coordinating themain
responses seen in chronic obstructive pulmonary disease (COPD) [1].
The major risk factor for COPD is cigarette smoke. Cigarette smoke con-
tributes to the development of the disease by a variety of mechanisms:
it affects chemotaxis, proliferation, and remodeling of extra-cellular
matrix in epithelial cells derived from normal human airways [2]. In
this context, alterations in epithelial repair may be important contribu-
tors to the architectural changes that can lead to airﬂow limitation
in COPD [3]. Alterations of airway epithelium, including squamous
cell metaplasia, goblet and basal cell hyperplasia, are often present
in smokers with and without COPD [4,5] and are considered by the
World Health Organization as pre-invasive precursor lesions for lung
cancer [6].ry disease; S, smokers; CSE,
ear antigen; IAPs, inhibitor of
yl ester
unologiaMolecolare-Consiglio
lermo, Italy. Tel.: +39 091 680
j).
rights reserved.Differentiation of multiple tissue types, including squamous
epithelia, is associated to an increased p21Waf1 expression. p21, act-
ing as a sensor of cellular stress, might have a role in lung responses
triggered by cigarette smoke [7]. In particular, the intracellular distri-
bution of p21 (nuclear or cytoplasmic) may have different functional
consequences. Nuclear p21 induces cell cycle arrest and differentia-
tion and it blocks DNA replication by binding to proliferating cell
nuclear antigen (PCNA) [8,9]. In oral squamous cell carcinoma, detect-
able nuclear p21 is associated with higher cell proliferation metaplastic
markers such as nuclear Ki67 [10]. Membranous and cytoplasmic Ki67
immunoreactivities have been observed in a number of histopathologi-
cal entities, including epithelial alterations in asthma [11] but the fre-
quency and the relationship to COPD have not been described yet [12].
Cytoplasmic p21 activity may be both pro-apoptotic and anti-
apoptotic depending also from the different cell phenotypes. Accordingly,
during monocyte differentiation cytoplasmic p21 inhibits the apoptosis
of these cells [8,13] and previous ﬁndings indicate that p21 plays a funda-
mental role in the protection against cytotoxic stimulation of certain cell
types. However, the mechanism by which p21 antagonizes apoptosis is
still unknown [13]. Apoptosis progression relies on the interplay between
pro-survival factors and pro-apoptotic factors, and this balance crucially
decides whether a cell under stress lives or dies. Pro-survival proteins,
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able to inhibit the apoptotic executors: i.e. cytoplasmic caspases [14].
Survivin levels are increased in smokers in comparison to non-smokers
and survivin expression in exhaled breath condensate in patients with
lung cancer positively correlates with the number of cigarettes smoked
[15].
The aims of our study are to assess whether cytoplasmic and
nuclear p21, Ki67, PCNA and survivin expression are altered in large
airway epithelium in smokers and in smokers with COPD and to
investigate whether these alterations contribute to the development
of airway epithelial squamous metaplasia.
2. Materials and methods
2.1. Study population
The study population of this study was recruited at ISMETT in
Palermo, Italy. All recruited patients underwent surgery for lung
cancer. The study protocol was approved by the ISMETT Ethic Com-
mittee (IRRB07/2008) and informed written consent was obtained
from each patient. The patients were classiﬁed into the following
groups as previously reported [16]: 1) non smoking patients (Controls)
without chronic pulmonary underlying events (n = 11); 2) smoking
patients (>15 pack/year) without COPD (S) (n = 12); 3) smoking pa-
tients (>15 pack/year) with COPD (s-COPD) (n = 17). COPD patients
were treated with bronchodilators and were classiﬁed on the basis of
preoperative lung function: FEV1 less than 80% of reference, FEV1/FVC
less than 70%, and broncho-dilatation reversibility less than 12%. The
following variables at admission were recorded: age, gender, smoking
habits (Table 1) (Supplemental materials).
2.2. Histology
Bronchial rings were taken from lung tissues, away from the tumor
site, ﬁxed (10% neutral buffer formalin) and embedded in parafﬁn wax.
A pathologist examined the bronchial rings and conﬁrmed that they
were tumor free and surrounded by tumor free tissue. Deparafﬁnized
sequential sections (4 μm thick) were stained with hematoxylin and
eosin (HE) and used for immunohistochemistry [17]. The following
antibodies were used: monoclonal mouse anti-p21 (sc-817; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) (1:10), monoclonal mouse anti-
caspase-3, speciﬁc for the active form, (Am-65; Calbiochem-Merck
KGaA, Darmstadt, Germany) (1:5), monoclonal mouse anti-Ki67 anti-
gen (M 7240 Clone MIB-1; DAKO, Glostrup, Denmark) (1:25), mono-
clonal mouse anti-PCNA (PC10-M0879; DAKO) (1:5), and rabbit
polyclonal anti-survivin (NB500-201; Novus Biologicals, Littleton, CO,
USA) (1:200); (heat pre-treatment at 92 °C; overnight incubation at
room temperature). The reaction was revealed by using the avidin–
biotin technique (AP-LSAB2 KIT; DAKO). An antibody diluent (DAKO)
and irrelevant rabbit or mouse antibodies (Santa Cruz Biotechnology)
of the same isotype were used as controls. The cell nuclei were stained
for 1 min with Hematoxylin (DAKO). The immunoreactivity in the ep-
ithelium of large airways (internal perimeter >6 mm) was evaluated
blindly by two independent investigators (G.C. and A.V.) and wasTable 1
Demographic characteristics.
Controls = 11 Smokers = 12 s-COPD = 17
Gender (M/F) 9/2 10/2 15/2
Age (years)
Means ± SD
60 ± 13 63 ± 9 64 ± 8
Packs/year – 59 ± 21 70 ± 31
FEV1% of predicted
Means ± SD
89 ± 16 77 ± 12 68 ± 15
FEV1/FVC % of predicted
Means ± SD
83 ± 6 80 ± 9 60 ± 7assessed as positive epithelial cells/mm basement membrane. Results
were expressed as medians and 25–75 percentiles [18]. Survivin
immunolocalization was assessed using a composite score [19,20].
Staining intensities were scored as no staining (0), weak staining [1],
moderate staining [2], or strong staining [3]. The percentage of staining
area was classiﬁed as 0 (0%); 1 (1–10%); 2 (11–50%); and 3 (51–100%).
Composite scores of 1–3 were deﬁned as having low survivin protein
expression, and scores of 4–9 were considered to be high expression
of survivin (Supplemental materials).2.3. Metaplastic bronchial epithelium analysis
Metaplastic epithelium analysis was performed by Image Analysis
software (Leica Quantimet system) [4]. The length of the basement
membrane was traced of all intact non-squamousmetaplastic epitheli-
um (A), intact squamous metaplastic epithelium (B), and damaged ep-
ithelium (C), in order to calculate the % of intact epithelium [(A + B) /
(A + B + C)] and the % of metaplastic epithelium [B / (A + B)]. In ad-
dition, the presence ofmetaplastic epitheliumwas also scored as absent
(0) or present (Supplemental materials).2.4. Preparation of cigarette smoke extracts (CSE)
Each cigarette (Marlboro)was smoked for 5 min in 25 ml phosphate-
buffered saline (PBS) and cigarette smoke solution was prepared as
described previously [21]. The CSE–PBS solution was ﬁltered through a
0.22-μmpore ﬁlter, adjusted to pH 7.4 and used within 30 min of prepa-
ration. This solution was considered to be 100% CSE (Supplemental
materials).Fig. 1. Cytoplasmic p21 expression in large airways. Immunohistochemistry for cyto-
plasmic p21 in surgical samples from Controls (n = 11), S (n = 12), and s-COPD
(n = 17) subjects. Cells were stained with an anti-p21 antibody (see Materials and
methods for details). Data are expressed as the number of positive epithelial cells/mm
basement membrane. Results are expressed as medians and 25th–75th percentiles.
*p b 0.05. Representative immunostaining in a Control, in a Smoker, and in a s-COPD at
400× magniﬁcation is shown.
Table 2
Cytoplasmic p21, nuclear p21, caspase-3, Ki67 and PCNA expression in bronchial epithelium.
Subjects group Control (C) Smokers
(S)
Smokers-COPD
(s-COPD)
(C) vs. (S) (C) vs.
(s-COPD)
(S) vs.
(s-COPD)
Cytoplasmic p21 3.1 (2.2–3.2) 25.5 (16.9–80) 28 (20–44.2) p b 0.0001 p b 0.0001 p = 0.6
Nuclear p21 2.3 (1.5–2.8) 7.9 (6.01–14.2) 5.8 (4.2–7.4) p b 0.0001 p b 0.0001 p = 0.1
Caspase-3 5 (0.8–2.9) 0.5 (0.35–3.85) 3.9 (0.5–4.5) p = 0.1 p = 0.2 p = 0.2
Ki67 2.7 (1.8–2.9) 11.1 (10.2–13.1) 15 (11.2–21.4) p b 0.0001 p b 0.0001 p = 0.1
PCNA 4.3 (4.1–4.7) 0.2 (0.15–0.23) 0.3 (0.14–0.3) p b 0.0001 p b 0.0001 p = 0.1
Results are expressed in medians; 25th–75th percentile values are shown in parenthesis.
Control (C), Smokers (S), Smokers-COPD (s-COPD).
A non-parametric Mann–Whitney test was then applied between two groups as the initial Kruskal–Wallis test was signiﬁcant.
Fig. 2. Nuclear p21 expression in large airways. Nuclear p21 in surgical samples from
Controls (n = 11), S (n = 12), and s-COPD (n = 17) subjects. Cells were stained
with an anti-p21 antibody (see Materials and methods for details). Data are expressed
as the number of positive epithelial cells/mm basement membrane. Results are
expressed as medians and 25th–75th percentiles. *p b 0.05. Representative immuno-
staining in a Control, in a Smoker, and in a s-COPD at 400× magniﬁcation is shown.
Arrows indicate nuclear p21 expression in S and s-COPD.
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The SV40 large T antigen-transformed 16HBE cell line is a cell line
that retains the differentiated morphology and function of normal
human airway epithelia [22]. 16HBE cells were plated in a 6 well
plate (4 × 105 cells/ml) (Dulbecco's modiﬁed Eagle's medium/FBS),
maintained at 37 °C in a humidiﬁed atmosphere (5% CO2) and when
at 70–80% conﬂuence incubated with/without 20% CSE for 24 h
(Supplementalmaterials). The concentration of 20% of CSEwas selected
on the basis of preliminary cytoﬂuorimetric experiments testing dif-
ferent CSE concentrations (5%, 10%, 20%) (Fig. S1—Supplemental
materials) on the expression of p21 and survivin.
2.6. Cell apoptosis by ﬂow-cytometry
Cell apoptosis was evaluated with and without CSE (20%), by
staining with Annexin V-Fluorescein Isothiocyanate and Propidium
Iodide using a commercial kit (Bender MedSystem, Vienna, Austria)
following the manufacturer's directions. Cells were analyzed using a
FACStar Plus (Becton Dickinson,Mountain View, CA, USA) as previously
described [21] (Supplemental materials).
2.7. Expression of p21, caspase 3 and survivin by ﬂow-cytometry
To evaluate the expression of p21, caspase-3, and survivin, 16HBE
cells were permeabilized using a commercial ﬁx-perm cell perme-
abilization kit (Caltag Laboratories, Burlingame, CA, USA), incubated in
the dark (30 min, 4 °C) with speciﬁc antibodies (see above) followed
by a Fluorescein Isothiocyanate-conjugated goat anti-mouse (DAKO)
or anti rabbit immunoglobulin G and then evaluated by ﬂow cytometry.
Mouse or rabbit negative control immunoglobulins (DAKO) were used
for negative controls. Data are expressed as Geo-mean ﬂuorescence
intensity.
2.8. Immunocytochemistry
16HBE cells were cultured with/without CSE 20% for 24 h and
were assessed for the expression of p21 and caspase-3 by immunocy-
tochemistry avidin–biotin technique (AP-LSAB2 KIT DAKO).
2.9. Cell proliferation assay
16HBE cell proliferation was measured using carboxyﬂuorescein
succinimidyl ester (CFSE) labeling assay [23]. CSE (20%) stimulated
16HBE were incubated with CFSE (Molecular Probes, Inc., Eugene,
OR) (at a ﬁnal concentration of 5 μM) at 37 °C for 10 min. Cell prolif-
eration was assessed by ﬂow-cytometry (Supplemental materials).
2.10. Statistical analysis
A non-parametric Mann–Whitney test was then applied between
two groups as the initial Kruskal–Wallis test was signiﬁcant for exvivo evaluations. Results are expressed as medians and 25th–75th
percentiles. *p b 0.05. Correlations were determined with a Spearman
rank correlation test. For survivin, correlations were performed using
staining intensities (0, 1, 2, 3). A p value of less than 0.05was considered
statistically signiﬁcant. Results are expressed as means ± SD and un-
paired t tests for in vitro experiments.3. Results
3.1. Demographic characteristics of the subjects
The demographic characteristics and the functional evaluations of
the studied groups are shown in Table 1. All recruited patient groups
were similar with regard to age. The number of packs/year was similar
between S and s-COPD (Table 1).
Fig. 3. Caspase-3 expression in large airways. Immunohistochemistry for caspase-3 in
surgical samples from Controls (n = 11), S (n = 12), and s-COPD (n = 17) subjects.
Cells were stained with an anti-caspase-3 antibody (see Materials and methods for
details). Data are expressed as the number of positive epithelial cells/mm basement
membrane. Results are expressed as medians and 25th–75th percentiles. Representa-
tive immunostaining in a Control, in a Smoker, and in a s-COPD at 400× magniﬁcation
is shown.
1476 G. Chiappara et al. / Biochimica et Biophysica Acta 1832 (2013) 1473–14813.2. Immunoreactivity of cytoplasmic and nuclear p-21 in
bronchial epithelium
We evaluated the expression of p-21 in bronchial epithelium.
The cytoplasmic p-21 immunoreactivity was signiﬁcantly increasedFig. 4. Survivin expression in large airways. Immunohistochemistry for survivin in surgical s
stained with an anti-survivin antibody (see Materials and methods for details). The intens
specimen (see Materials and methods for details). Representative immunostaining in a Conin S and in s-COPD in comparison to Controls (Fig. 1) (Table 2). The
p-21 immunoreactivity was present both in the basal and in columnar
epithelial cells and was concentrated in the cytoplasm of metaplastic
epithelial cells. The nuclear p-21 immunoreactivity was signiﬁcantly
increased in S and in s-COPD in comparison to control subjects (Fig. 2)
(Table 2). The immunoreactivity was present both in the basal and in
columnar epithelial cells (Fig. 2).
3.3. Immunoreactivity of caspase-3 in bronchial epithelium
The caspase-3 immunoreactivity in bronchial epithelium was
similar in all study groups (Fig. 3) (Table 2). The immunoreactivity
was present both in the basal and in columnar epithelial cells (Fig. 3).
3.4. Immunoreactivity of survivin in bronchial epithelium
The cytoplasmic survivin immunoreactivity was present in the
basal and in columnar epithelial cells and higher expression of survivin
(score 4–9) was observed in the cytoplasm of metaplastic epithelium
rather than in the non metaplastic epithelium. The higher expression
of survivin (score 4–9) was present in the majority of S and of s-COPD
but only in one of the controls (Fig. 4) (Table 2).
3.5. Immunoreactivity of PCNA in bronchial epithelium
The PCNA immunoreactivity was signiﬁcantly decreased in S and
in s-COPD in comparison to Controls (Fig. 5) (Table 2). The immuno-
reactivity was present in the basal and in columnar epithelial cells
and was localized in cytoplasm and nuclei (Fig. 5).
3.6. Immunoreactivity of Ki67 in bronchial epithelium
The Ki67 immunoreactivity in bronchial epithelium was signiﬁ-
cantly increased in S and in s-COPD in comparison to control subjects
(Fig. 6) (Table 2). The immunoreactivity was present in the basal and
in columnar epithelial cells and was mainly concentrated in the cyto-
plasm (Fig. 6).amples from Controls (n = 11), S (n = 12), and s-COPD (n = 17) subjects. Cells were
ity and percentage scores were multiplied to give a composite score of [1–9] for each
trol, in a Smoker, and in a s-COPD at 400× magniﬁcation is shown.
Fig. 5. PCNA expression in central airways. Immunohistochemistry for PCNA in surgical
samples from Controls (n = 11), S (n = 12), and s-COPD (n = 17) subjects. Cells
were stained with an anti-PCNA antibody (see Materials and methods for details).
Data are expressed as the number of positive epithelial cells/mm basement membrane.
Results are expressed as medians and 25th–75th percentiles. *p b 0.05. Representative
immunostaining in a Control, in a Smoker, and in a s-COPD at 400× magniﬁcation is
shown.
Fig. 6. Ki67 expression in large airways. Immunohistochemistry for Ki67 in surgical
samples from Controls (n = 11), S (n = 12), and s-COPD (n = 17) subjects. Cells
were stained with an anti-ki67 antibody (see Materials and methods for details).
Data are expressed as the number of positive epithelial cells/mm basement membrane.
Results are expressed as medians and 25th–75th percentiles. *p b 0.05. Representative
immunostaining in a Control, in a Smoker, and in a s-COPD at 400× magniﬁcation is
shown.
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Morphometric analysis in central airways of all recruited subjects
showed an increased percentage of metaplastic epithelium in S and in
s-COPD in comparison to control subjects (Fig. 7).3.8. Correlations
Correlations between the number of cytoplasmic and nuclear p21,
PCNA and Ki67 positive cells and metaplastic squamous bronchial
epithelium in central airways of S and s-COPDwere assessed. A positive
correlation was found between cytoplasmic or nuclear p21 and meta-
plastic squamous bronchial epithelium in central airways of S and
s-COPD (Table 3). A negative correlation was found between nuclear
p21 and PCNAwhile a positive correlationwas observed between cyto-
plasmic p21 and Ki67 inmetaplastic squamous bronchial epithelium in
central airways of S and s-COPD (Table 3). Furthermore, a positive cor-
relation was found between Ki67 andmetaplastic squamous bronchial
epithelium in central airways of S and s-COPD (Table 3). Cytoplasmic
and nuclear p21, Ki67 and survivin positively correlated while PCNA
negatively correlated with packs/year of smoke (Table 3).3.9. Effects of CSE on the apoptosis and proliferation of bronchial
epithelial cells (16HBE)
The effects of CSE in a bronchial epithelial cell line were tested.
CSE were able to increase at higher extent cytoplasmic than nuclear
p21 in 16HBE (Fig. 8) but did not induce caspase-3 expression or
cell apoptosis (Annexin V binding) in these cells (Fig. 9). Moreover,
CSE increased survivin expression, but reduced cell proliferation in
16HBE (CFSE assay) (Fig. 10).Fig. 7. Morphometric analysis in large airways. Squamous cell metaplasia in smokers
and s-COPD is higher than control (smokers vs. Controls p = 0.0008 and s-COPD vs.
Controls p = 0.0004). Representative immunostaining in a Control, in a Smoker, and
in a s-COPD at 100× magniﬁcation is shown.
Table 3
Correlations.
Spearman correlation
Cytoplasmic p21 vs. metaplastic epithelium Rho = 0.789 p b 0.0001
Nuclear p21 vs. metaplastic epithelium Rho = 0.69 p b 0.0001
Nuclear p21 vs. PCNA Rho = −0.572 p = 0.0006
Ki67 vs. metaplastic epithelium Rho = 0.638 p b 0.0001
Cytoplasmic p21 vs. Ki67 Rho = 0.78 p b 0.0001
p21 cytoplasmic vs. packs/years Rho = 0.686 p b 0.0001
Active-caspase-3 vs. packs/year Rho = −0.19 p = 0. 3
Ki67 vs. packs/year Rho = 0.7 p b 0.0001
PCNA vs. packs/year Rho = −0.5 p = 0.064
p21 nuclear vs. packs/year Rho = 0.4 p = 0.005
Survivin vs. packs/year Rho = 0. 855 p b 0.0001
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Injury to superﬁcial airway epithelium is normally accompanied
by mitotic activity in the remaining cells and rapid restoration of the
denuded surface. Tobacco smoke is the major etiological factor for the
development of COPD and is a potent stimulus of DNA damage by oxi-
dant injury. Tobacco smoke may affect the expression and activity of
proteins associated with cell proliferation and cell apoptosis thus alter-
ing physiological reparative mechanisms. Smoking contributes to COPD
occurrence andprogression accelerating the rate of decline in lung func-
tion and this decline was proportional to pack/years smoked [24].
The present study demonstrates for the ﬁrst time that in large
airway epithelium of smokers and s-COPD: 1) the cytoplasmic p21,Fig. 8. Effects of CSE in p21 expression of 16HBE. p21 expression was assessed by ﬂow cytom
upon CSE 20% stimulation (n = 3). A. Data are expressed as Geo-mean ﬂuorescence intensity
Arrows indicate curves relative to baseline and to CSE 20%. C. Representative immunostain
expression.nuclear p-21 and survivin immunoreactivity is increased; and 2) the
PCNA immunoreactivity is decreased. Furthermore, a negative corre-
lation was observed between nuclear p21 and PCNA while a positive
correlation was observed between cytoplasmic p21 and Ki67 in bron-
chial metaplastic squamous epithelium. In vitro experiments, using a
bronchial epithelial cell line, demonstrated that CSE increase survivin
expression and, at higher extent, cytoplasmic than nuclear p21. Dif-
ferently, CSE do not induce caspase-3 expression or cell apoptosis
(Annexin V binding) and reduce cell proliferation.
The starting hypothesis of our study was that cigarette smoke could
lead to an imbalance between apoptosis and proliferation of bronchial
epithelial cells affecting the expression and the sub-cellular distribution
of p21. p21 belongs to the Cip/kip family, proteins inhibiting a variety
of cyclin-dependent kinase activities [25]. p21 is highly responsive to
oxidative stress and may play a role in the cellular processes involving
the imbalance of cell proliferation/apoptosis [26]. On the basis of its
sub-cellular distribution, nuclear or cytoplasmic p21 may affect both
cell proliferation and cell apoptosis. Cytoplasmic p21 plays an important
role in regulating apoptotic processes. It is well known that oxidative
stress induced by cigarette smoke may contribute to chronic airway
inﬂammation through a reduction of apoptosis in alveolarmacrophages
(AMs) and bronchial epithelial cells [27]. In this regard, it has been pre-
viously demonstrated that alveolarmacrophages andbronchial epithelial
cells from smokers have reduced cell death aswell as increased cytoplas-
mic p21 expression [27]. p21 is a substrate for executive caspases such as
caspase-3 and this kind of degradation can be reversed by speciﬁc
caspase inhibitors [28]. Indeed, cytoplasmic p21 activity may be both
pro-apoptotic and anti-apoptotic [13] in different cell phenotypes [8]etry (A–B) and by immunohistochemistry LSAB technique (C) in 16HBE at baseline and
± SD. *p b 0.05. B. Representative histogram plots of the p21 expression with overlay.
ing at 400× and at 1000× magniﬁcation. Arrows indicate cytoplasmic and nuclear p21
Fig. 10. Survivin expression and CFSE assay by ﬂow cytometry in 16HBE. Survivin expression (A) and cell proliferation (B) using carboxyﬂuorescein succinimidyl ester (CFSE)
labeling assay was evaluated by ﬂow cytometry in 16HBE at baseline and upon CSE 20% stimulation. A. Data are expressed as Geo-mean ﬂuorescence intensity ± SD. *p b 0.05.
Representative histogram plot of the survivin expression with overlay. Arrows indicate curves relative to baseline and to CSE 20%. B. Data are expressed as percentage of CFSE
positive cells ± SD. Representative histogram plots for cell proliferation assay.
Fig. 9. Effects of CSE in caspase 3 expression and annexin V binding of 16 HBE. Expression of caspase 3 (A–B) and cell apoptosis by PI/Annexin V binding method (D) was evaluated
by ﬂow-cytometry in 16HBE at baseline and upon CSE 20% stimulation (n = 3). Expression of caspase 3 was also assessed by immunohistochemistry LSAB technique (C). A. Data
are expressed as Geo-mean ﬂuorescence intensity ± SD. B. Representative histogram plots of the caspase 3 expression with overlay. C. Representative immunostaining at 400×
magniﬁcation. D. Representative dot plots for assessing cell apoptosis by PI/Annexin V method. The propidium and Annexin V double-positive cells (i.e. late apoptotic cells)
were present in the upper right quadrant and the single Annexin-V-positive cells (i.e. early apoptotic cells) were present in the lower right quadrant.
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family of evolutionary conserved pro-survival proteins, IAPs, is essential
in protecting cells from entering apoptosis by negative regulation of
downstream caspases. Survivin is the smallest member of the IAP family
and exhibits anti-apoptotic characteristics since its cytoplasmic localiza-
tion, supporting the pro-caspase 3/p21 complex, leads to anti-apoptosis
[14]. In the present study, in large airway epithelium of S and s-COPD,
the cytoplasmic p21 and survivin immunoreactivity was increased
while the activated caspase-3 immunoreactivity was similar in all study
groups, thus supporting the concept that these molecular events lead
to a protection of the epithelium from cell apoptosis. Alterations ob-
served in large airways [16,29] do not always reﬂect those present in
small airways and future experiments are needed to clarify whether
the alterations observed in the present study in large airways are also
present in small airways. Furthermore, these alterations are speciﬁcally
related to smoke exposure and not to the presence of the cancer since
all the recruited patients including the control group were affected by
lung cancer. Further evidences have been provided by the in vitro exper-
iments which demonstrate that cigarette smoke induces cytoplasmic
p21 and survivin without inducing caspase 3 or cell apoptosis in bron-
chial epithelial cells.
On the other hand, nuclear p21, mainly involved in regulating cell
proliferation, is also increased in the large airway epithelium of S and
s-COPD. The intracellular nuclear accumulation of p21 may be one of
the mechanisms by which cigarette smoke induces inhibition of cell
proliferation. In the present study, in vitro, CSE inhibit the prolifera-
tion of bronchial epithelial cells according to previous results on alve-
olar type II epithelial cells [30]. p21 inhibits cyclin-dependent kinases
and interacts with PCNA blocking its activities and its interactions
with other PCNA binding proteins. PCNA, originally characterized
as a DNA polymerase accessory protein, interacting with multiple
partners is involved in DNA repair, DNA methylation and chromatin
assembly. Recent ﬁndings revealed that p21 undergoes proteosomal
degradation when it directly engages PCNA [31]. This PCNA mediated
degradation pathway of p21 seems to be linked only to chromatin
bound PCNA and not to free PCNA [31]. Here, nuclear and cytoplasmic
p-21 immunoreactivity was signiﬁcantly increased while PCNA im-
munoreactivity was signiﬁcantly decreased in basal and in columnar
epithelial cells of S and of s-COPD in comparison with control sub-
jects. It is conceivable that PCNA decrease, leading to a reduced deg-
radation of p21, may contribute to the increase in p21 in S and in
s-COPD observed in the present study. Differently, Ki67 immunoreac-
tivity, another proliferation marker, was signiﬁcantly increased in ep-
ithelial cells of S and of s-COPD in comparison with control subjects.
In this regard, it has been demonstrated that cigarette smoke appears
to elicit a dose-related proliferative response in the bronchial epithe-
lium of active smokers measured by the Ki-67 proliferation index
[32]. Molecular changes (allelic loss and genomic instability) in the
bronchial epithelium may persist long after smoking cessation [33].
Ki-67 is an antigen associated with nuclear proliferation, and it is
expressed during the growth and synthesis phases of the cell cycle,
but not during the resting phase [34]. This antigen provides informa-
tion about the proportion of active cells in the cell cycle. Ki-67 is
signiﬁcantly increased in subjects with intestinal metaplasia [35],
in bronchial epithelium of severe asthma [36] and after allergen
exposure in bronchial epithelium of atopic asthmatics in relation to
bronchial epithelial metaplasia [11]. Ki-67 expression is increased in
smokers, is higher in male than in female and increases with increas-
ing levels of histologic dysplasia [37].
In oral squamous cell carcinoma, detectable nuclear p21 is associ-
ated with higher Ki-67 expression [10] and differentiation of multiple
tissue types, including squamous epithelia, is associated to an in-
creased p21 expression [26]. It is well known that there is a relation
between epithelial cell proliferation and differentiation. Ki-67+ cell
numbers and the squamous cell metaplasia were positively associated
[4]. According to these data, we now here show a correlation betweenthe increase of Ki67 expression and squamous cell metaplasia in cen-
tral airways of smokers and of s-COPD. Unfortunately, in our study
the recruited subjects were predominantly men and this limitation
did not allow to assess whether the alterations of the studied markers
were present in women, a population more susceptible to smoke
exposure than male [38].
Moreover, in bronchial biopsies from smokers with bronchitis or
COPD, in which goblet cell hyperplasia and squamous metaplasia
are often seen, emerging data indicate that the mitotic response may
be suppressed [39]. The altered cell differentiation and thedevelopment
of cell metaplasia may be related not only to altered cell proliferation
but also to altered cell apoptosis as conﬁrmed here by the ﬁndings
that higher expression of survivin is present in themetaplastic epithelium
and that cytoplasmic or nuclear p21 correlate with metaplastic epithe-
lium. In this regard, it has been demonstrated that survivin is not
expressed in normal bronchial epithelium and that its levels are
increased in smokers in comparison to non-smokers prevalently in
metaplastic areas of the bronchi [40]. Nicotine increases the transcrip-
tion of the survivin gene in non-small cell lung cancer cells and we
now conﬁrm that cigarette smoke extracts increase survivin in a bron-
chial epithelial cell line [41]. Furthermore, squamous cell metaplasia is
considered by the World Health Organization as a pre-invasive precur-
sor lesion for lung cancer [6].
In conclusion, our study shows that, in bronchial airways of current
smokers with and without COPD, cigarette smoke, altering expression
and sub-cellular distribution of p21, may play an important role in
the imbalance between apoptosis, proliferation, and differentiation of
bronchial epithelial cells leading to squamousmetaplasia, an alteration
associated with increased airway obstruction of COPD and with
increased risk of lung cancer in smokers [42].
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbadis.2013.04.022.
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